From: Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial
UC-MSCS (% of patients)
PLACEBO (% of patients)
p-value
9 weeks
8.89
2.27
0.3607
20 weeks
15.56
9.09
0.3542
32 weeks
48 weeks
20.00
4.55
0.0268